Older adults with type 1 diabetes face significant global disparities in access to insulin and essential medical care resources.

People with T2D are more likely to achieve long-term remission after weight-loss surgery than after intensive medical and lifestyle management.

Older adults with long-standing type 1 diabetes experience a high prevalence of obstructive sleep apnea risk and poor sleep quality.

Researchers investigated the association between daily vaping intensity and early cardiovascular risk markers in a young adult population.

Elevated menopause proteomic scores are associated with poorer cognitive outcomes and increased risk for Alzheimer disease and dementia.

Retatrutide therapy significantly decreases body weight and improves knee osteoarthritis pain and events in OSA in adults with obesity.

Semaglutide provides multifaceted kidney protection and improves structural markers in patients with T2D and chronic kidney disease.

Off-label testosterone prescriptions for women have surged; most are not for the approved indication of hypoactive sexual ...

Sustained smoking cessation for at least 8 years significantly reduces risk for microvascular complications in patients with type 2 diabetes.

High-dose oral menopausal hormone therapy increases risk for venous thromboembolism, ischemic stroke, and myocardial infarction.

Dual-hormone fully closed-loop therapy increases time in glycemic range compared with multiple daily insulin injections (MDI), but not compared with hybrid closed-loop (HCL) therapy in adults with ...

GLP-1 RAs and SGLT-2 inhibitors reduce risk for renal deterioration in patients with type 2 diabetes (T2D) and albuminuria.